Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Aug 21, 2025; 31(31): 109857
Published online Aug 21, 2025. doi: 10.3748/wjg.v31.i31.109857
Figure 2
Figure 2 Prognosis in groups divided according to > 12 or < 12 negative lymph nodes. A: Negative lymph node (NLN) status predicting disease-free survival (P = 0.058); B: NLN status predicting overall survival (P = 0.190); C: NLN status predicting cancer-specific survival (P = 0.110). NLN: Negative lymph node.